A. Grigg

1.1k total citations
37 papers, 825 citations indexed

About

A. Grigg is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, A. Grigg has authored 37 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in A. Grigg's work include Hematopoietic Stem Cell Transplantation (15 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (5 papers). A. Grigg is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (5 papers). A. Grigg collaborates with scholars based in Australia, Canada and New Zealand. A. Grigg's co-authors include Jeff Szer, John F. Seymour, Ashish Bajel, Andrew W. Roberts, Monica A. Slavin, G. L. Phillips, Anne R. Buckley, Karin Thursky, Allen Cheng and Michelle Ananda‐Rajah and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

A. Grigg

36 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Grigg Australia 18 377 272 179 154 146 37 825
Nobuhiko Uoshima Japan 15 336 0.9× 311 1.1× 153 0.9× 200 1.3× 61 0.4× 58 839
EP Smith United States 8 387 1.0× 256 0.9× 101 0.6× 134 0.9× 108 0.7× 11 697
A Iriondo Spain 19 625 1.7× 255 0.9× 130 0.7× 116 0.8× 72 0.5× 45 1.0k
Shogo Banno Japan 19 204 0.5× 275 1.0× 192 1.1× 148 1.0× 103 0.7× 91 1.1k
Adina Cioc United States 15 276 0.7× 264 1.0× 98 0.5× 133 0.9× 121 0.8× 33 793
Roberta H. Adams United States 15 371 1.0× 172 0.6× 192 1.1× 90 0.6× 71 0.5× 53 818
Roni Tamari United States 18 601 1.6× 278 1.0× 205 1.1× 176 1.1× 135 0.9× 98 977
Ryan DeMasi United States 14 387 1.0× 236 0.9× 163 0.9× 137 0.9× 97 0.7× 30 1.1k
Marianna Criscuolo Italy 21 481 1.3× 194 0.7× 233 1.3× 128 0.8× 87 0.6× 72 1.0k
N Gratecos France 13 704 1.9× 306 1.1× 191 1.1× 176 1.1× 85 0.6× 46 1.2k

Countries citing papers authored by A. Grigg

Since Specialization
Citations

This map shows the geographic impact of A. Grigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Grigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Grigg more than expected).

Fields of papers citing papers by A. Grigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Grigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Grigg. The network helps show where A. Grigg may publish in the future.

Co-authorship network of co-authors of A. Grigg

This figure shows the co-authorship network connecting the top 25 collaborators of A. Grigg. A scholar is included among the top collaborators of A. Grigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Grigg. A. Grigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shanmuganathan, Naranie & A. Grigg. (2024). A critical review of management of allogeneic transplant‐eligible adults with Ph+ acute lymphoblastic leukaemia. British Journal of Haematology. 208(1). 39–53.
2.
Grigg, A., Belinda Butcher, Ashish Bajel, et al.. (2017). An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trial. Bone Marrow Transplantation. 52(9). 1288–1293. 9 indexed citations
3.
Gregory, Gareth P., Kah Lok Chan, Constantine S. Tam, et al.. (2013). Rituximab is associated with improved survival for aggressive B cell CNS lymphoma. Neuro-Oncology. 15(8). 1068–1073. 54 indexed citations
4.
Hoegh-Petersen, Mette, Alejandra Ugarte-Torres, Tyler Williamson, et al.. (2012). Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse. Bone Marrow Transplantation. 48(1). 105–114. 26 indexed citations
5.
Ross, David M., et al.. (2011). Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features. Haematologica. 96(11). 1720–1722. 20 indexed citations
6.
7.
Al‐Badriyeh, Daoud, Monica A. Slavin, Danny Liew, et al.. (2010). Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia. Journal of Antimicrobial Chemotherapy. 65(5). 1052–1061. 28 indexed citations
8.
Mason, Kylie D., Seong Lin Khaw, Kathleen C. Rayeroux, et al.. (2009). The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. Leukemia. 23(11). 2034–2041. 78 indexed citations
9.
Ng, Ashley P., et al.. (2008). Thrombotic thrombocytopenic purpura is associated with a high relapse rate after plasma exchange: a single‐centre experience. Internal Medicine Journal. 39(1). 19–24. 9 indexed citations
10.
Hertzberg, Mark, A. Grigg, David Gottlieb, et al.. (2006). Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders. Bone Marrow Transplantation. 37(10). 923–928. 13 indexed citations
11.
12.
Ritchie, David, A. Grigg, Andrew W. Roberts, et al.. (2004). Staged autologous peripheral blood progenitor cell transplantation for Ewing sarcoma and rhabdomyosarcoma. Internal Medicine Journal. 34(7). 431–434. 6 indexed citations
13.
Grigg, A. & Elizabeth O’Flaherty. (2001). Cyclosporin A for the Treatment of Pure Red Cell Aplasia Associated with Myelodysplasia. Leukemia & lymphoma. 42(6). 1339–1342. 7 indexed citations
14.
Grigg, A.. (2001). 2′-Deoxycoformycin for Hepatosplenic γδ T-Cell Lymphoma. Leukemia & lymphoma. 42(4). 797–799. 22 indexed citations
15.
Grigg, A. & Elizabeth O’Flaherty. (2001). Cyclosporin a for the Treatment of Pure Red Cell Aplasia Associated with Myelodysplasia. Leukemia & lymphoma. 42(6). 1339–1342. 8 indexed citations
16.
Wolf, M., JP Matthews, J. Stone, et al.. (2000). Dose-intensification does not improve outcome in aggressive non-Hodgkin's lymphoma (NHL). Report of a randomized trial by the Australasian Leukemia and Lymphoma Group (ALLG).. Blood. 96(11). 2 indexed citations
17.
Nicholson, I., Michael D. Varney, A. Grigg, et al.. (1997). Alloresponses to HLA-DP Detected in the Primary MLR: Correlation with a Single Amino Acid Difference. Human Immunology. 55(2). 163–169. 23 indexed citations
18.
Grigg, A., et al.. (1996). Multi-organ dysfunction associated with high-dose carboplatin therapy prior to autologous transplantation.. PubMed. 17(1). 67–74. 4 indexed citations
19.
Grigg, A., et al.. (1995). G-CSF Stimulated Donor Granulocyte Collections for Neutropenic Sepsis. Leukemia & lymphoma. 18(3-4). 329–334. 15 indexed citations
20.
Goss, Glenwood, et al.. (1994). Hansenula anomala infection after bone marrow transplantation.. PubMed. 14(6). 995–7. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuhiko Uoshima Breakdown of academic impact, for papers by EP Smith Breakdown of academic impact, for papers by A Iriondo Breakdown of academic impact, for papers by Shogo Banno Breakdown of academic impact, for papers by Adina Cioc Breakdown of academic impact, for papers by Roberta H. Adams Breakdown of academic impact, for papers by Roni Tamari Breakdown of academic impact, for papers by Ryan DeMasi Breakdown of academic impact, for papers by Marianna Criscuolo Breakdown of academic impact, for papers by N Gratecos
Rankless by CCL
2026